Train at NCI’s Post

Priyanka Bhakhri--a Georgetown Biotech colleague--published an informative and insightful article during their time at the Broad Institute of MIT and Harvard. In it, the authors discuss the concept of a decentralized, patient-partnered research platform that empowers patients with rare cancers, like angiosarcoma, and more common cancers, like breast cancer, to contribute data and samples remotely as a means to address and set a foundation for more equitable rare cancer research.

I am honored to have been selected for the prestigious Global Alliance for Chronic Diseases (GACD) Implementation Science School 2024! Being part of this diverse cohort of 41 researchers from around the world is an incredible opportunity to dive deeper into implementation science, a field that is urgently needed, especially in regions like ours where generating evidence often takes precedence over implementing and sustaining that evidence. In our part of the world, the focus remains heavily on producing data and evidence, but implementation science takes it one step further. It asks, how can we effectively put this evidence into practice? It tackles the real-world challenges of turning research into action, ensuring that the findings we work so hard to generate make a lasting impact on people’s lives. I’m excited to take this journey with a passionate group of researchers and apply what we learn to address critical gaps in the implementation and sustainability of evidence-based practices. Congratulations to all my fellow participants, and here's to making a tangible difference together in the global fight against non-communicable diseases! #ImplementationScience #GACDSchool2024 #GlobalHealth #NonCommunicableDiseases #EvidenceToImpact

Novel exciting study by Betty Kim, Weng Jiang and collaborators!

Second Ph.D. paper from Luke Trinity's thesis is out now -- "Tying the knot: Unraveling the intricacies of the coronavirus frameshift pseudoknot". In this study, we employed the KnotAli and Shapify algorithms to enhance our knowledge of RNA structures in coronaviruses, including SARS-CoV-2. By examining the frameshift elements in 181 coronavirus RNA sequences, we identified crucial structural transitions that could improve the targeting of antiviral therapies. This research not only deepens our understanding of RNA structure-function relationships but also propels the development of innovative treatments for those impacted by these viruses. #Virology #RNAresearch #Coronavirus #covid19 RNA Canada ARN (formerly called Canadian Consortium of RNA Researchers) University of Alberta

“I was always interested in engineering cells for better function.” 2020 BYI John Blazeck, PhD, Assistant Professor at the Georgia Institute of Technology shares about the research journey working on synthetic antibody repertoires for vaccine development, therapeutic isolation, and the study of adaptive immunity. Watch the video: https://ow.ly/vPfl50ThT8S #immunoengineering #immunology #engineering #metabolism #humanhealth #proteinengineering #cellularengineering #byi #phd #academia #lab #research #scientist #vaccinedesign #syntheticbiology #personalizedmedicine #enzymeengineering #customantibodies #like #follow #comment #researcherlife #scientistlife

Two incredible UTS researchers, Dr Jiao Jiao Li and Dr Gang Liu, have each been awarded $1 million fellowships by The Rebecca L. Cooper Medical Research Foundation. Their work aims to improve the lives of thousands of Australians suffering from joint and respiratory diseases. Read the full story 🔗 https://lnkd.in/gZGRZa7k

Celebrating #MentalHealthAwarenessMonth! Amidst challenges, our students, especially the Class of 2024, have shown incredible resilience. At UC Irvine Public Health, we prioritize trauma-informed care, environmental awareness, and equity-focused practices to nurture resilient leaders. Curious to learn more about the impactful work our researchers, students, and faculty are conducting? Dive into our May monthly newsletter below for inspiring stories and insights! https://lnkd.in/gsY7EJ8U #MentalHealthAwareness

Idiopathic pulmonary fibrosis (IPF) is a relatively rare disease that causes the lungs to scar and stop working. More than 2,000 Australians are diagnosed each year with this devastating condition, which has no known cause or cure. People with IPF typically survive two to five years after being diagnosed.   My research aims to develop new and more effective therapies for this debilitating condition. This program will improve diagnosis by creating new AI software, explore how fibrosis progresses at the cellular level using large-scale biology data, and optimise treatments to halt and hopefully reverse this progress using gene therapies.   Thank you to The Rebecca L. Cooper Medical Research Foundation supporting me and my research being conducted at UTS.   Congratulations also to Dr Jiao Jiao Li with her research also receiving funding from the Fellowship. https://lnkd.in/gz-grAhz

With slides from the research to practice presentation

Are you an early-career physician or scientist living outside of the United States? The Association of Black Cardiologists, Inc. is excited to launch a competition that focuses on research that demonstrates innovation, rigor, and a commitment to addressing global cardiovascular health challenges, particularly in underrepresented populations. Applicants will need to submit an original cardiovascular research in clinical, basic, or population science. Learn more: https://bit.ly/4jticPl